Pfizer, Apotex Agree To Settle Over Lipitor

Law360, New York (August 8, 2008, 12:00 AM EDT) -- Pfizer Inc. has agreed to settle its patent lawsuit against Canadian drugmaker Apotex Inc., possibly ending the fight over the production of the generic versions of Pfizer's blockbuster cholesterol-reducing drug, Lipitor.

Pfizer reported the settlement in a terse note to its quarterly report, filed with the U.S. Securities and Exchange Commission on Friday.

According to the drug giant's 10-Q filing, “As previously reported, we are involved in litigation with Apotex Inc. with respect to certain of our patents for Lipitor in Canada. In July 2008, we...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.